Announcements Trials
Browse Landscape

Phase

Phase 2 45Phase NA 35Phase 3 11Phase 1/2 8Phase 1 7Phase 2/3 4Phase EARLY_PHASE1 3

Status

Unknown 4Recruiting 4Completed 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 2Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 1Pancreatic Adenocarcinoma 1NSCLC 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Cisplatin 20Docetaxel 19Capecitabine 19Oxaliplatin 14Drug Therapy 14Cyclophosphamide 14Paclitaxel 13Fluorouracil 12Radiotherapy 11apatinib 9Gemcitabine 9Doxorubicin 9Decitabine 9Methotrexate 8Epirubicin 8Carboplatin 8sintilimab 6Etoposide 6camrelizumab 5anlotinib 5XELOX 5Sorafenib 5Radiation 5Pemetrexed 5Neoadjuvant Therapy 5Leucovorin 5Idarubicin 5Dexamethasone 5Cytarabine 5Busulfan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × Unknown × Radiosurgery × Clear all
NCT03256981 2023-12-26

HALT

Institute of Cancer Research, United Kingdom

Phase 2/3 Unknown
113 enrolled
Thoracic

NSCLC

NCT05181605 2022-08-09

Survival Analysis After Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer and Risk Factors

Instituto de investigación e innovación biomédica de Cádiz

Phase 2/3 Unknown
116 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma

NCT04167293 2021-03-23

ISBRT01

Sun Yat-sen University

Phase 2/3 Unknown
116 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02759783 2019-08-21

CORE

Royal Marsden NHS Foundation Trust

Phase 2/3 Unknown
245 enrolled
BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡